Eli Lilly, Novo Nordisk to take care of ‘two horse race’ in GLP-1 weight reduction market
U.Ozel.Photos/E+ by way of Getty Photos Though different firms are poised to have GLP-1 receptor agonist medication for weight reduction…
U.Ozel.Photos/E+ by way of Getty Photos Though different firms are poised to have GLP-1 receptor agonist medication for weight reduction…
Julie Denesha/Getty Photographs Information Spirit AeroSystems Holdings (NYSE:SPR) on Monday mentioned its quarterly loss deepened with a decline in shipments…